Status Approved
First Submitted Date
2017/06/10
Registered Date
2017/07/20
Last Updated Date
2017/06/29
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0002382 |
---|---|
Unique Protocol ID | HPIRB 2016-10-012-002 |
Public/Brief Title | Gait chage after gartrocnemius & soloeus endoscopic release in patients with cerebral palsy |
Scientific Title | Gait chage after gartrocnemius & soloeus endoscopic release in patients with cerebral palsy |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | HPIRB 2016-10-012-002 |
Approval Date | 2016-11-02 |
Institutional Review Board Name | Inje University HAeundae Paik Hospital Institutional Review Board |
Institutional Review Board Address | |
Institutional Review Board Telephone | |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Kunbo Park |
Title | MD |
Telephone | +82-2-2228-2195 |
Affiliation | Yonsei University |
Address | 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea |
Contact Person for Public Queries | |
Name | Kunbo Park |
Title | MD |
Telephone | +82-2-2228-2195 |
Affiliation | Yonsei University |
Address | 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea |
Contact Person for Updating Information | |
Name | Kunbo Park |
Title | MD |
Telephone | +82-2-2228-2195 |
Affiliation | Yonsei University |
Address | 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Completed | |
Date of First Enrollment | 2016-11-02 Actual | |
Target Number of Participant | 30 | |
Primary Completion Date | 2017-01-31 , Actual | |
Study Completion Date | 2017-02-10 , Actual | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Inje University Haeundae Paik Hospital | |
Recruitment Status | Completed | |
Date of First Enrollment | 2016-11-02 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Inje University Haeundae Paik Hospital |
Organization Type | Medical Institute |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Inje University Haeundae Paik Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | Several methods exist for lengthening of triceps surae for the correction of ankle equinus, such as tendo-achilles lengthening, gastrocsoleus recession, and intramuscular lengthening. Gastrocsoleus recession results in greater muscle lengthening than does intramuscular lengthening, and is also more stable than tendo-achilles lengthening in terms of overcorrection. The only issue is the incision scar and the possibility of sural nerve injury. Endoscopic gastrocnemius recession yields a smaller incision and is associated with lower prevalence of nerve injury. The small incision is also important in single-event multi-level surgery in patients with cerebral palsy (CP). However, the optimal lengthening is more important because of crouch gait after overcorrection or re-operation for the recurrence of equinus after under correction in CP. Although short-term evaluations after endoscopic gastrocnemius-soleus recession in patients with CP have been reported previously, to our knowledge, there have been no reports after long term follow-up gait analysis. Furthermore, there was no definite description about the lengthening method in terms of Baumann, Strayer, Vulpius, or Baker in the endoscopic recession technique. If the gait improvement and long-term follow-up outcome of endoscopic gastrocsoleus recession in patients with CP is comparable to that of open surgery, the endoscopic surgery would be better for patients who underwent a single-event multi-level surgery (SEMLS). Endoscopic transverse Vulpius surgery has been performed in our institute as a part of SEMLS for 5 years. The purpose of our study was to compare the surgical outcomes between open and endoscopic transverse Vulpius surgeries in terms of scar formation and gait improvement. |
---|
8. Study Design
Study Type | Observational Study |
---|---|
Observational Study Model | Case-only |
Time Perspective | Retrospective |
Target Number of Participant | 30 |
Cohort/Group Number | 1 |
Cohort/ Group 1 |
Cohort/Group Label Cerebral palsy patients who had undergone endoscopic transverse Vulpius surgery |
Cohort/Group Description Scar, 3-dimensional gait analysis and ankle range of motion in Cerebral palsy patients who had undergone endoscopic transverse Vulpius surgery |
|
Biospecimen Collection & Archiving |
Not collect nor Archive |
Biospecimen Description |
9. Subject Eligibility
Study Population Description | Cerebral palsy patients who had undergone endoscopic transverse Vulpius surgery |
---|---|
Sampling Method | Medical record review and recruit non-probabilistic all Cerebral palsy patients who had undergone endoscopic transverse Vulpius surgery |
Condition(s)/Problem(s) |
* (G00-G99)Diseases of the nervous system (G80.9)Cerebral palsy, unspecified |
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 5Year~12Year |
|
Description spastic diplegia, independent walker, and more than 2 years of follow-up gait analysis |
|
Exclusion Criteria |
previous surgeries before the index operation, Botox injection within 6 months from the surgery, and surgery after skeletal maturation |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Improvement in Gait analysis |
|
Timepoint | Postoperative 2 years |
|
Primary Outcome(s) 2 | ||
Outcome | , Operation scar |
|
Timepoint | Postoperative 2 years |
|
Secondary Outcome(s) 1 | ||
Outcome | ankle dorsiflexion angle with knee flexion and extension |
|
Timepoint | Postoperative 2 years |
11. Study Results and Publication
Result Registered |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | Yes |
---|---|
Time of Sharing | 2021. 11 |
Way of Sharing | Available on Request
(kunbopark@gmail.com) |
TOP
BOTTOM
화면 최하단으로 이동